Advertisement
Advertisement

MGNX

MGNX logo

MacroGenics, Inc.

3.60
USD
Sponsored
+0.17
+4.80%
Apr 10, 15:59 UTC -4
Closed
exchange

After-Market

3.65

+0.04
+1.11%

MGNX Earnings Reports

Positive Surprise Ratio

MGNX beat 18 of 41 last estimates.

44%

Next Report

Date of Next Report
May 11, 2026
Estimate for Q1 26 (Revenue/ EPS)
$15.95M
/
-$0.54
Implied change from Q4 25 (Revenue/ EPS)
-61.32%
/
+134.78%
Implied change from Q1 25 (Revenue/ EPS)
+20.88%
/
-16.92%

MacroGenics, Inc. earnings per share and revenue

On Mar 09, 2026, MGNX reported earnings of -0.23 USD per share (EPS) for Q4 25, beating the estimate of -0.29 USD, resulting in a 22.40% surprise. Revenue reached 41.23 million, compared to an expected 23.10 million, with a 78.50% difference. The market reacted with a -1.73% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 6 analysts forecast an EPS of -0.54 USD, with revenue projected to reach 15.95 million USD, implying an increase of 134.78% EPS, and decrease of -61.32% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Omeros Corporation
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$0.58
Actual
$0.98
Surprise
+268.56%
logo
Tilray Brands, Inc. Common Stock
Report Date
Apr 01, 2026 For Q3 26
Estimate
-$0.14
Actual
-$0.24
Surprise
-68.07%
logo
FitLife Brands, Inc. Common Stock
Report Date
Mar 31, 2026 For Q4 25
Estimate
$0.21
Actual
$0.16
Surprise
-25.22%
logo
Neogen Corp
Report Date
Apr 09, 2026 For Q3 26
Estimate
$0.05
Actual
$0.09
Surprise
+53.32%
logo
IM Cannabis Corp. Common Shares
Report Date
Mar 30, 2026 For Q4 25
Estimate
$0.12
Actual
-$1.19
Surprise
-1055.53%
FAQ
For Q4 2025, MacroGenics, Inc. reported EPS of -$0.23, beating estimates by 22.4%, and revenue of $41.23M, 78.5% above expectations.
The stock price moved down -1.73%, changed from $1.73 before the earnings release to $1.70 the day after.
The next earning report is scheduled for May 11, 2026.
Based on 6 analysts, MacroGenics, Inc. is expected to report EPS of -$0.54 and revenue of $15.95M for Q1 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement